EUVIMEDOpdag EUVIMED
Übersichtsarbeit

Impact of the COVID‐19 pandemic on melanoma diagnosis and presentation: a `review

James E Fanning, Simran Kalsi, David N Krag

International Journal of Dermatology · 2023

DOI: 10.1111/ijd.16684 ↗

At a glance

Übersichtsarbeit in International Journal of Dermatology, 2023. Written by James E Fanning and 2 co-authors. Institution: Larner College of Medicine, University of Vermont, Burlington, VT, USA. Major MEDLINE topics: COVID-19, Melanoma, Skin Neoplasms. Cited 10 times so far (Crossref); 13 references.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

The ongoing challenges posed by COVID‐19 are concerning for their impact on successful detection and recognition of melanoma as total body skin examinations and skin biopsies are critical for identifying early‐stage melanoma and intervening before progression to metastatic disease. A comprehensive electronic search of PubMed/MEDLINE was conducted on or before August 1, 2022, using the search terms (“skin” AND “COVID‐19”), ([“skin cancer” AND “COVID‐19”] OR [“skin cancer” AND “coronavirus”]), ([“melanoma” AND “COVID‐19”] OR [“melanoma” AND “coronavirus”]), (“dermatology” AND “COVID‐19”), and (“cutaneous” AND “COVID‐19”). Eight articles representing Belgium, Chile, France, Germany, Spain, the United Kingdom, and the United States were included. Four articles analyzed changes in the proportion of in situ melanoma at diagnosis and consistently reported decreases, with an overall decrease ranging from 7.6 to 40.4%. Five studies analyzed changes in the proportion of melanoma diagnoses by staging, but no clear changes in staging patterns were observed. Five studies analyzed changes in the mean Breslow thickness of melanoma diagnoses and consistently reported increases, with an overall increase ranging from 4.0 to 38%. Disruptions to proper diagnosis and treatment of melanoma are creating undue morbidity, mortality, and healthcare costs as the pandemic continues. Continued research with improved, centralized data collection is needed to better address the COVID‐19 pandemic's ongoing challenge to appropriate detection and treatment of melanoma.

Subjects

MeSH terms (MEDLINE)

COVID-19MelanomaSkin NeoplasmsHumansUnited StatesPandemicsSensitivity and SpecificityCOVID-19 Testing

Authors and institutions

  • Larner College of Medicine, University of Vermont, Burlington, VT, USA.
  • Department of Surgery, Larner College of Medicine, University of Vermont Cancer Center, University of Vermont, Burlington, VT, USA.

Cite

APA

Fanning, J. E., Kalsi, S., & Krag, D. N. (2023). Impact of the COVID‐19 pandemic on melanoma diagnosis and presentation: a `review. International Journal of Dermatology. https://doi.org/10.1111/ijd.16684

Vancouver

Fanning JE, Kalsi S, Krag DN. Impact of the COVID‐19 pandemic on melanoma diagnosis and presentation: a `review. International Journal of Dermatology. 2023. doi:10.1111/ijd.16684

BibTeX
@article{Fanning2023,
  author = {Fanning, James E and Kalsi, Simran and Krag, David N},
  title = {Impact of the COVID‐19 pandemic on melanoma diagnosis and presentation: a `review},
  journal = {International Journal of Dermatology},
  year = {2023},
  doi = {10.1111/ijd.16684}
}
Start for free →